Greenwich LifeSciences
GLSI
64 hedge funds and large institutions have $41.1M invested in Greenwich LifeSciences in 2026 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 9 closing their positions.
167% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 9
50% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 12
48% more capital invested
Capital invested by funds: $27.9M → $41.1M (+$13.3M)
28% more funds holding
Funds holding: 50 → 64 (+14)
2.79% more ownership
Funds ownership: 9.58% → 12.36% (+2.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nuveen
Charlotte,
North Carolina
|
+$2.31M |
| 2 |
BlackRock
New York
|
+$1.63M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
+$1.02M |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$978K |
| 5 |
State Street
Boston,
Massachusetts
|
+$942K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Credit Agricole
Montrouge Cedex,
France
|
-$1.83M |
| 2 |
VF
Virtu Financial
New York
|
-$605K |
| 3 |
Man Group
London,
United Kingdom
|
-$590K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$249K |
| 5 |
Barclays
London,
United Kingdom
|
-$224K |
GLSI Hedge Fund Activity: Q1 2026 in Review
64 of the 8,198 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q1 2026, worth a combined $41.1M — up 48% from $27.9M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new GLSI positions and 9 closed out — a net gain of 15 holders — while 18 added to existing stakes and 12 trimmed.
The largest buyer was Nuveen, opening a new position worth an estimated $2.31M. The largest seller was Credit Agricole, exiting entirely with an estimated $1.83M sold.
- 64 institutional investors held Greenwich LifeSciences (GLSI) as of Q1 2026, up from 50 in Q4 2025.
- Funds reported $41.1M of Greenwich LifeSciences stock for Q1 2026, up 48% quarter-over-quarter.
- 24 funds opened new Greenwich LifeSciences positions in Q1 2026 and 9 closed out, a net change of +15 holders.
- The largest Greenwich LifeSciences buyer in Q1 2026 was Nuveen, an estimated $2.31M added.
- The largest Greenwich LifeSciences seller in Q1 2026 was Credit Agricole, an estimated $1.83M sold.
Based on aggregated 13F filings for Q1 2026.